Metraipolis › archive › dc_ae40020bc426

Will the introduction of β-lactamase inhibitors alter the adverse event profile of parent penicillins antibiotics? a pharmacovigilance study based on… — Europe PMC PMID:41908814

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41908814
DOI
10.3389/fphar.2026.1772354
License (as archived)
solo-consultazione
Archived
2026-11-04T18:41:38.859Z
SHA-256 of the archived text
ef3c0eefe2e5597cbfb9fdce69e5d39c2cfa15dba22f07babcbfaa1b1c0e5851
Stable URL of this page
https://metraipolis.com/documento/dc_ae40020bc426

How to cite

Will the introduction of β-lactamase inhibitors alter the adverse event profile of parent penicillins antibiotics? a pharmacovigilance study based on… — Europe PMC PMID:41908814 — Europe PMC (en), https://europepmc.org/article/MED/41908814 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ae40020bc426 (Metraipolis archive dc_ae40020bc426, sha256 ef3c0eefe2e5597cbfb9fdce69e5d39c2cfa15dba22f07babcbfaa1b1c0e5851)
BibTeX
@misc{dcae40020bc426,
  title = {Will the introduction of β-lactamase inhibitors alter the adverse event profile of parent penicillins antibiotics? a pharmacovigilance study based on… — Europe PMC PMID:41908814},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41908814},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ae40020bc426; sha256 ef3c0eefe2e5597cbfb9fdce69e5d39c2cfa15dba22f07babcbfaa1b1c0e5851},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41908814. Agents can read the archived copy with the MCP tool read_document.